Manufacturing Execution System Providers in Healthcare by Type of Deployment (Cloud, Corporate Datacenter, Hybrid and On Premise), Type of End-User (Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    September 2022

  • Slides
    144

  • View Count
    289

Example Insights

Manufacturing-Execution-System-Providers-Context-thumb Manufacturing-Execution-System-Providers-List-of-Companies-thumb Manufacturing-Execution-System-Providers-Different-Licensing-Models-thumb
Manufacturing-Execution-System-Providers-In-Healthcare-thumb Manufacturing-Execution-System-Providers-Partnerships-And-Collaborations-thumb Manufacturing-Execution-System-Providers-Company-Competitiveness-Analysis-thumb
Manufacturing-Execution-System-Providers-Value-Creation-Framework-thumb Manufacturing-Execution-System-Providers-Opportunity-thumb  

Overview

Incorporation of MES into production line can streamline material cost and time spent in production. I believe, MES has the potential to reduce 10%-30% of the overall production cost, depending on the type of industry

-- CEO, a small-sized company

Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at an annualized growth rate of 36%. However, it is important to consider that the constant management of such enormous volumes of data is a tedious and challenging process. Specifically, management and handling of huge datasets in the healthcare industry often requires a large workforce of specialized personnel. According to the American Hospital Association, by 2026, there is likely to be a shortage of 3.2 million healthcare workers. The continuously growing data, coupled to the projected deficit of healthcare workers, would inadvertently generate pressure on healthcare manufacturers to adopt novel tools / technologies that can improve management efficiency and better utilize the available, expensive resources. Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution systems (MES).

In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate a manufacturing execution system into their production lines, with an aim to connect, monitor and control the complex manufacturing process. In addition, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volume of data from various sources, as well as to produce value in the form of insights, predictions and actions. According to industry experts, manufacturing execution systems has the potential to reduce 10%-30% of the overall production cost depending on the type of industry. It has further been observed that companies are increasingly adopting cloud-based manufacturing execution system, to overcome the challenges associated with growing complexity of processes and global expansion of businesses. Specifically, cloud-based manufacturing execution systems integrate real-time information of different production floors and promotes collaboration. Considering the rising demand for such systems, presently, more than 75 companies claim to offer manufacturing execution systems, based on several deployment models, to the healthcare sector. It is worth mentioning that, in the past few years, substantial acquisition activity has been reported in the manufacturing execution systems market, as players strive to become one-stop-shops, to cater to the diverse needs of the healthcare sector. Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive growth over the coming years.

Scope of the Report

The “Manufacturing Execution System Providers Market in Healthcare by Type of Deployment (Cloud, Corporate Datacenter, Hybrid  and On Premise), Type of End-User (Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study of the current market landscape and future opportunity for players engaged in offering manufacturing execution systems in the healthcare sector. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features.

A general introduction to manufacturing execution systems, along with information on their core functions. Additionally, it includes details on the various deployment models adopted by providers. Further, it features a brief discussion on the key advantages and disadvantages associated with manufacturing execution systems in the healthcare sector.

  • A detailed overview of the current market landscape of manufacturing execution system providers in the healthcare industry, along with information on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters (North America, Europe and Asia), type of deployment (cloud, corporate datacenter, hybrid and on premise), integrating software (enterprise resource planning, human resource management, manufacturing operation management and product lifecycle management), type of license (perpetual, subscription), type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), key features (data integration, document control, performance analysis, production tracking), type of service(s) offered (general support, implementation / upgradation, training) and quality certifications received (ISA-95, ISA-88, ISO 9001, ISO 14001, ISO 13485).
  • An in-depth analysis, highlighting the contemporary market trends using five schematic representations, including [A] a vertically grouped bar chart, based on year of establishment and region of headquarters, [B] a horizontally stacked bar chart, based on company size and type of deployment, [C] a waffle chart representation, based on type of license and end-user, [D] a mekko chart representation, based on company size and key features, and [E] a 4D bubble chart comparing the players engaged in this domain, based on several relevant parameters (such as year of establishment, company size, deployment type and quality certifications).
  • An analysis of recent partnerships inked between various stakeholders engaged in this domain, during the period 2018-2022, based on several relevant parameters, such as year of partnership, type of partnership model adopted (acquisitions, distribution agreements, service agreements, service alliances, technology integration agreements and technology utilization agreements), type of partner (automation industry, biotechnology, information technology and others), key players (in terms of number of partnerships) and regional distribution.
  • An insightful competitiveness analysis of manufacturing execution system providers in the healthcare industry based on several relevant parameters, such as product portfolio strength (in terms of years of experience of the packaging provider), competitive index (in terms of type of deployment, type of license, type of end-user, key features, type of service(s) offered and quality certifications) and partnership strength (taking into consideration the number of partnerships and type of agreement).
  • Elaborate profiles of key players engaged in the domain of manufacturing execution system providers. Each company profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters and key executives, recent developments and an informed future outlook.
  • An insightful framework depicting the implementation of several advanced tools and technologies, such as artificial intelligence, cloud computing, internet of things and machine learning, in different production stages / functions, which can assist service providers in addressing existing unmet needs. Further, it provides a detailed analysis on ease of implementation and associated risk in integrating above-mentioned technologies, based on the trends highlighted in published literature and patents. 
  • A detailed market forecast analysis, highlighting the likely growth of the manufacturing execution system providers in the healthcare market, for the period 2022-2035. Additionally, the report features the likely distribution of the current and forecasted opportunity across [A] type of deployment (cloud, corporate datacenter, hybrid and on premise), [B] type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), and [C] key geographical regions (North America, Europe, Asia, Middle East and North Africa, Latin America and Rest of the World). In order to account for future uncertainties and add robustness to our forecast model, we have provided three scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • A collection of interview transcripts of discussions held with key stakeholders in this industry. In this chapter, we have presented the details of our conversations held with Carine van Godtsenhoven (Chief Marketing Officer, ORDINAL Software), Philip Borland (Chief Executive Officer, NoMuda), Yaron Halfon (Director of Sales, Trunovate).

Key Questions Answered

  • Who are the key players engaged in offering manufacturing execution systems for the healthcare sector?
  • Which type of deployment is most commonly adopted by manufacturing execution system providers in the healthcare sector?
  • What is the relative competitiveness of different manufacturing execution system providers for the healthcare sector?
  • Which partnership models are most commonly being adopted by stakeholders engaged in this industry?
  • What is the unmet need within this domain and how can the ongoing advancements in technologies enable enhanced efficiency of overall manufacturing execution systems?
  • How is the current and future opportunity likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of key insights captured during our research. It offers a high-level view on the likely evolution of the manufacturing execution system providers in the healthcare sector, in the short to mid-term and long term.

Chapter 3 provides a general introduction to manufacturing execution systems, along with information on their core functions. Additionally, it includes details on the various deployment models adopted by providers. Further, it features a brief discussion on the key advantages and disadvantages associated with manufacturing execution systems in the healthcare sector. 

Chapter 4 provides a detailed overview of the current market landscape of manufacturing execution system providers in the healthcare sector, along with information on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters (North America, Europe and Asia), type of deployment (cloud, corporate datacenter hybrid and on premise), integrating software (enterprise resource planning, human resource management, manufacturing operation management and product lifecycle management), type of license (perpetual, subscription), type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), key features (data integration, document control, performance analysis, production tracking), type of service(s) offered (general support, implementation / upgradation, training) and quality certifications received (ISA-95, ISA-88, ISO 9001, ISO 14001, ISO 13485).

Chapter 5 features an in-depth analysis, highlighting  the contemporary market trends using five schematic representations, including [A] vertical grouped bar chart based on year of establishment and region of headquarters, [B] a horizontal stacked bar chart based on company size and type of deployment, [C] a waffle chart based on type of license and end- user, [D] a mekko chart based on company size and key features, and [E] a 4D bubble analysis, comparing the players engaged in this domain, based on several relevant parameters (such as year of establishment, company size, deployment type and quality certifications).

Chapter 6 features an analysis of recent partnerships inked between various stakeholders engaged in this domain, during the period 2018-2022, based on several relevant parameters, such as year of partnership, type of partnership model adopted (acquisitions, distribution agreements, service agreements, service alliances, technology integration agreements and technology utilization agreements), type of partner (automation industry, biotechnology, information technology and others), key players (in terms of number of partnerships) and regional distribution.

Chapter 7 insightful competitiveness analysis of manufacturing execution system providers in healthcare based on several relevant parameters, such as product portfolio strength (in terms of years of experience of the packaging provider), competitive index (in terms of type of deployment, type of license, type of end-user, key features, type of service(s) offered and quality certifications) and partnership strength (taking into consideration the number of partnerships and type of agreement).

Chapter 8 includes elaborate profiles of key players engaged in this domain of manufacturing execution system providers. Each company profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters and key executives, recent developments and an informed future outlook. 

Chapter 9 features an insightful framework depicting the implementation of several advanced tools and technologies, such as artificial intelligence, cloud computing, internet of things and machine learning, in different production stages / functions, which can assist service providers in addressing the existing unmet needs. Further, it provides a detailed analysis on ease of implementation and associated risk in integrating above-mentioned technologies, based on the trends highlighted in published literature and patents.

Chapter 10 features a detailed market forecast analysis, highlighting the likely growth of the manufacturing execution system providers in the healthcare market, for the period 2022-2035. Additionally, the report features the likely distribution of the current and forecasted opportunity across [A] type of deployment (cloud, corporate datacenter, hybrid and on premise), [B] type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), and [C] key geographical regions (North America, Europe, Asia, Middle East and North Africa, Latin America and Rest of the World).

Chapter 11 presents the summary of the entire report. Additionally, in this chapter, we have provided a list of key takeaways from the report and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 12 is a collection of interview transcripts of discussions held with key stakeholders in this industry. In this chapter, we have presented the details of our conversations held with Carine van Godtsenhoven (Chief Marketing Officer, ORDINAL Software), Philip Borland (Chief Executive Officer, NoMuda), Yaron Halfon (Director of Sales, Trunovate).

Chapter 13 is an appendix I, which presents all the additional figures of the report

Chapter 14 is an appendix II, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 15 is an appendix III, which contains the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION 
3.1. Overview of Manufacturing Execution Systems
3.2. Core Function of Manufacturing Execution Systems
3.3 Deployment Models of Manufacturing Execution Systems
3.4 Benefits Offered by Manufacturing Execution Systems
3.5 Challenges Associated with Manufacturing Execution Systems
3.6 Integration of Manufacturing Execution Systems for Different Operations
3.7 Concluding Remarks

4. MARKET LANDSCAPE 
4.1. Manufacturing Execution System Providers in Healthcare: Market Overview
4.2. List of Manufacturing Execution System Providers in Healthcare
4.3. Analysis by Year of Establishment
4.4. Analysis by Company Size
4.5. Analysis by Location of Headquarters
4.6. Analysis by Type of Deployment
4.7. Analysis by Integrating Software
4.8. Analysis by Type of License
4.9. Analysis by Type of End User
4.10. Analysis by Key Features
4.11. Analysis by Type of Service(s) Offered
4.12. Analysis by Quality Certifications Received

5. KEY INSIGHTS
5.1. Analysis by Year of Establishment and Region of Headquarters
5.2. Analysis by Company Size and Type of Deployment
5.3. Analysis by Type of License and End User
5.4. Analysis by Company Size and Key Features
5.5. Analysis by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received (4D Bubble Chart)

6. PARTNERSHIPS AND COLLABORATIONS 
6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
6.2. Analysis by Year of Partnership
6.3. Analysis by Type of Partnership
6.4. Analysis by Year of Partnership and Type of Partnership
6.5. Analysis by Type of Partnership and Company Size
6.6. Key Players: Analysis by Number of Partnerships
6.7. Analysis by Type of Partner
6.8. Analysis by Country
6.9. Analysis by Region
6.10. Intercontinental and Intracontinental Deals 
6.11. Analysis by Location of Headquarters of Partner
6.12. Analysis by Type of Partnership and Location of Headquarters of Partner 

7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Manufacturing Execution System Providers in Healthcare: Company Competitiveness Analysis
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Partnership Activity
7.6. Company Competitiveness Analysis: Very Large Players 
7.7. Company Competitiveness Analysis: Large Players 
7.8. Company Competitiveness Analysis: Mid-Sized Players
7.9. Company Competitiveness Analysis: Small Players 

8. COMPANY PROFILES
8.1. Andea
8.1.1 Company Overview
8.1.2. Technology Portfolio
8.1.3. Recent Developments and Future Outlook

8.2. Critical Manufacturing
8.2.1 Company Overview
8.2.2. Technology Portfolio
8.2.3. Recent Developments and Future Outlook

8.3. Dassault Systèmes
8.3.1 Company Overview
8.3.2. Technology Portfolio
8.3.3. Recent Developments and Future Outlook

8.4. GE Digital
8.4.1 Company Overview
8.4.2. Technology Portfolio
8.4.3. Recent Developments and Future Outlook

8.5. Infor
8.5.1 Company Overview
8.5.2. Technology Portfolio
8.5.3. Recent Developments and Future Outlook

8.6. Körber
8.6.1 Company Overview
8.6.2. Technology Portfolio
8.6.3. Recent Developments and Future Outlook

8.7. Rockwell Automation
8.7.1 Company Overview
8.7.2. Technology Portfolio
8.7.3. Recent Developments and Future Outlook

9. VALUE CREATION FRAMEWORK: A STRATEGIC GUIDE TO ADDRESS UNMET NEED FOR MANUFACTURING EXECUTION SYSTEMS
9.1. Unmet Need for Manufacturing Execution Systems in the Healthcare Industry
9.2. Key Assumptions and Methodology
9.3. Key Tools and Technologies
9.3.1. Technology 1
9.3.2. Technology 2
9.3.3. Technology 3
9.3.4. Technology 4
9.4. Extent of Innovation versus Associated Risks
9.5 Concluding Remarks

10. MARKET FORECAST
10.1. Key Assumptions and Forecast Methodology
10.2. Forecasted Market Segments 
10.3. Manufacturing Execution System Providers in Healthcare Market, 2022-2035

10.4. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of Deployment, 2022-2035
10.4.1. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions
10.4.2. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions
10.4.3. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions
10.4.4. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions

10.5. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of End User, 2022-2035
10.5.1. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies
10.5.2. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers
10.5.3. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies
10.5.4. Manufacturing Execution System Providers in Healthcare Market for Other End Users

10.6. Manufacturing Execution System Providers in Healthcare Market: Analysis by Geography, 2022-2035
10.6.1. Manufacturing Execution System Providers in Healthcare Market in North America, 2022-2035
10.6.2. Manufacturing Execution System Providers in Healthcare Market in Europe, 2022-2035
10.6.3. Manufacturing Execution System Providers in Healthcare Market in Asia, 2022-2035
10.6.4. Manufacturing Execution System Providers in Healthcare Market in Latin America, 2022-2035
10.6.5. Manufacturing Execution System Providers in Healthcare Market in MENA, 2022-2035
10.6.6. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, 2022-2035

11. CONCLUSION

12. EXECUTIVE INSIGHTS 
12.1. NoMuda
12.1.1. Company Snapshot
12.1.2. Interview Transcript: Philip Borland (Chief Executive Officer)

12.2. ORDINAL Software
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Carine van Godtsenhoven (Chief Marketing Officer)

12.3. Trunovate
12.3.1. Company Snapshot
12.3.2. Interview Transcript: Yaron Halfon (Director of Sales)

13. APPENDICES I: OTHER FIGURES
13.1. Market Overview
13.2. Key Insights
13.3. Partnerships and Collaborations
13.4. List of Figures

14. APPENDICES II: TABULATED DATA

15. APPENDICES III: LIST OF COMPANIES

List Of Figures

Figure 3.1. Core Function of Manufacturing Execution Systems
Figure 3.2. Deployment Models of Manufacturing Execution Systems
Figure 3.3. Benefits and Challenges of Manufacturing Execution Systems
Figure 3.4. Integration of Manufacturing Execution Systems for Different Operations
Figure 4.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
Figure 4.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
Figure 4.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
Figure 4.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
Figure 4.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
Figure 4.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
Figure 4.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
Figure 4.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
Figure 4.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
Figure 5.1. Key Insights: Distribution by Year of Establishment and Region of Headquarters
Figure 5.2. Key Insights: Distribution by Company Size and Type of Deployment
Figure 5.3. Key Insights: Distribution by Type of License and End User
Figure 5.4. Key Insights: Distribution by Company Size and Key Features
Figure 5.5. Key Insights: Distribution by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received
Figure 6.1. Partnerships and Collaborations: Distribution by Year of Partnership
Figure 6.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 6.3. Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 6.4. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 6.5. Partnerships and Collaborations: Key Players by Number of Partnerships
Figure 6.6. Partnerships and Collaborations: Distribution by Type of Partner
Figure 6.7. Partnerships and Collaborations: Distribution by Country
Figure 6.8. Partnerships and Collaborations: Distribution by Region
Figure 6.9. Intercontinental and Intracontinental Deals
Figure 7.1. Company Competitiveness Analysis: Benchmarking of Portfolio Strength
Figure 7.2. Company Competitiveness Analysis: Benchmarking of Partnership Activity
Figure 7.3. Company Competitiveness Analysis: Very Large Players
Figure 7.4 .Company Competitiveness Analysis: Large Players
Figure 7.5 .Company Competitiveness Analysis: Mid-Sized Players
Figure 7.6. Company Competitiveness Analysis: Small Players
Figure 9.1. Value Creation Framework: Trends in Research Activity related to Integration of Key Tools and Technologies with Manufacturing Execution System
Figure 9.2. Value Creation Framework: Trends in Intellectual Property related to Integration of Key Tools and Technologies with Manufacturing Execution System
Figure 9.3. Value Creation Framework: Extent of Innovation versus Associated Risk Matrix
Figure 9.4. Value Creation Framework: Comparison of Key Tools / Technologies
Figure 10.1. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, 2022-2035
Figure 10.2. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
Figure 10.3. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
Figure 10.4. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
Figure 10.5. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
Figure 10.6. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, 2022-2035
Figure 10.7. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
Figure 10.8. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
Figure 10.9. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
Figure 10.10. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
Figure 10.11. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, 2022-2035
Figure 10.12. Manufacturing Execution System Providers in Healthcare Market in North America, 2022-2035
Figure 10.13. Manufacturing Execution System Providers in Healthcare Market in Europe, 2022-2035
Figure 10.14. Manufacturing Execution System Providers in Healthcare Market in Asia, 2022-2035
Figure 10.15. Manufacturing Execution System Providers in Healthcare Market in Latin America, 2022-2035
Figure 10.16. Manufacturing Execution System Providers in Healthcare Market in MENA, 2022-2035
Figure 10.17. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, 2022-2035
Figure 11.1. Concluding Remarks: Current Market Landscape
Figure 11.2. Concluding Remarks: Partnerships and Collaborations
Figure 11.3. Concluding Remarks: Value Creation Framework
Figure 11.4. Concluding Remarks: Market Forecast

List Of Tables

Table 4.1. Manufacturing Execution System Providers in Healthcare: Information on Year of Establishment, Headquarters, Company Size and Name of Solution
Table 4.2. Manufacturing Execution System Providers in Healthcare: Information on Type of Deployment, Integrating Software, Type of License, Type of End User, Key Features, Type of Service(s) Offered and Quality Certifications Received
Table 6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
Table 14.1. Manufacturing Execution System Providers in Healthcare Distribution by Year of Establishment
Table 14.2. Manufacturing Execution System Providers in Healthcare: Distribution by Company Size
Table 14.3. Manufacturing Execution System Providers in Healthcare: Distribution by Location of Headquarters
Table 14.4. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Deployment
Table 14.5. Manufacturing Execution System Providers in Healthcare: Distribution by Integrating Software
Table 14.6. Manufacturing Execution System Providers in Healthcare: Distribution by Type of License
Table 14.7. Manufacturing Execution System Providers in Healthcare: Distribution by Type of End User
Table 14.8. Manufacturing Execution System Providers in Healthcare: Distribution by Key Features
Table 14.9. Manufacturing Execution System Providers in Healthcare: Distribution by Type of Service(s) Offered
Table 14.10. Partnerships and Collaborations: Distribution by Year of Partnership
Table 14.11. Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.12. Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 14.13. Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 14.14. Partnerships and Collaborations: Key Players by Number of Partnerships
Table 14.15. Partnerships and Collaborations: Distribution by Type of Partner
Table 14.16. Partnerships and Collaborations: Distribution by Country
Table 14.17. Partnerships and Collaborations: Distribution by Region
Table 14.18. Intercontinental and Intracontinental Deals
Table 14.19. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of Deployment, 2022-2035
Table 14.20. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions (USD Billion)
Table 14.21. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions (USD Billion)
Table 14.22. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions (USD Billion)
Table 14.23. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions (USD Billion)
Table 14.24. Manufacturing Execution System Providers in Healthcare Market: Distribution by Type of End User, 2022-2035
Table 14.25. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies (USD Billion)
Table 14.26. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers (USD Billion)
Table 14.27. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies (USD Billion)
Table 14.28. Manufacturing Execution System Providers in Healthcare Market for Other End Users (USD Billion)
Table 14.29. Manufacturing Execution System Providers in Healthcare Market: Distribution by Geography, 2022-2035
Table 14.30. Manufacturing Execution System Providers in Healthcare Market in North America, 2022-2035
Table 14.31. Manufacturing Execution System Providers in Healthcare Market in Europe, 2022-2035
Table 14.32. Manufacturing Execution System Providers in Healthcare Market in Asia, 2022-2035
Table 14.33. Manufacturing Execution System Providers in Healthcare Market in Latin America, 2022-2035
Table 14.34. Manufacturing Execution System Providers in Healthcare Market in MENA, 2022-2035
Table 14.35. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, 2022-2035

List Of Companies

  1. 42Q
  2. ABB
  3. Absolute EMS
  4. Aegis Software
  5. AltaVista
  6. Andea
  7. Applied Materials
  8. Apprentice
  9. Aptean
  10. Arcstone
  11. Aspen Technology
  12. Atachi Systems
  13. Aveva
  14. Amazon Web Services
  15. AX for Pharma
  16. B. Braun
  17. Birlasoft
  18. CAI Software
  19. CalcuQuote
  20. camLine
  21. CESMII
  22. CIMx Software
  23. CircuitByte
  24. Cogiscan
  25. Creonis
  26. Critical Manufacturing
  27. Cyient
  28. Dassault Systèmes
  29. DigiProces
  30. Emerson
  31. Enlight Technologies
  32. Epicor
  33. Eyelit
  34. FACTIVITY
  35. FAST Technologies
  36. Fastec 
  37. FORCAM
  38. FrontWell Solutions
  39. Fujitsu
  40. GE Digital
  41. GFOS
  42. Guardus Solutions
  43. HCL
  44. Hexagon
  45. Hitachi
  46. Honeywell
  47. HVR
  48. iBASEt
  49. IMCO Software
  50. Immunotech Biopharm
  51. Infor
  52. Infoteam Automation
  53. inmation
  54. Integer
  55. Intraratio 
  56. Inventrax 
  57. DELMIAWorks Manufacturing
  58.  iTAC Software
  59. I-Track Software
  60. Katana Technologies
  61. Körber
  62. L3Harris Technologies 
  63. Laurus Infosystems
  64. Leanios
  65. Lighthouse Systems
  66. Lynq
  67. LZ Lifescience
  68. MACS
  69. ECI
  70. MESTEC
  71. Metronik
  72. Miracom
  73. Modula
  74. MPDV
  75. NoMuda
  76. Novaspect 
  77. Nymi
  78. Open Data
  79. Oracle
  80. Ordinal Software
  81. Parsec
  82. Performix
  83. Plex
  84. POMS 
  85. Premier 
  86. Prodexis
  87. Prodsmart
  88. PTC
  89. Qualitas Informatica
  90. Qubes
  91. QZing Technology
  92. Radixweb
  93. Radley
  94. Rockwell Automation
  95. Samsung SDS
  96. Sanmina
  97. SAP
  98. SERO
  99. Siemens
  100. Sisteplant
  101. Smart Pharma Soft Solutions
  102. SwissSEM
  103. Tata Consultancy Services 
  104. Throughput Consulting
  105. tisoware Gesellschaft für Zeitwirtschaft
  106. TrakCel
  107. Trunovate
  108. Tulip
  109. Vimachem
  110. Vineti
  111. Walvax Biotechnology
  112. Yokogawa
  113. ZEISS

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com